 በጥር 2019 ኤፍዲኤ ለታመሙ የካቦዛንቲኒብ ጽላቶች አፀደቀ hepatocellular ካርሲኖማ (ኤች.
Bishii Janaayo 2019, FDA waxay ansixisay kiniiniyada 'cabozantinib' ee bukaannada qaba kansarka hepatocellular (HCC) oo horay loogu daweeyay sorafenib.